Caso
SMILE monovision
Un tratamiento efectivo y seguro para pacientes amétropes y présbitas
9 septiembre 2019
· 2 MIN LEER
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.100.100.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg"})
Autor
Jakob Siedlecki, Dr. en Medicina
Profesional de oftalmología, Universidad Ludwig-Maximilians de Múnich en Múnich, Alemania
RESUMEN
Estudio de caso de SMILE monovision
El caso presenta SMILE como una buena opción de tratamiento para pacientes amétropes y présbitas que deseen prescindir de las gafas para usar el ordenador y disfrutar de aficiones como deportes acuáticos.
El caso confirma que SMILE:
- Es un tratamiento efectivo y seguro.
- Es una buena alternativa de cirugía refractiva corneal con minimonovisión.
- Es una solución para los pacientes amétropes y présbitas con cristalino transparente.
- Proporciona mayor independencia de las gafas para la mayoría de actividades diarias.